Navamedic ASA: Mandatory notice of trade
Reading Time: < 1 minute Oslo, November 6, 2024: Lars Hjarrand, CFO and a primary insider of Navamedic ASA, has today bought 20.000 Navamedic ASA shares at an average price of NOK 23,80 per share. See attachment for further details about the transaction. Following this
Temporary change in Polymer Factory’s management team 2025 – CEO takes parental leave
Reading Time: < 1 minute Mats Wallnér, board member of Polymer Factory Sweden AB (publ), will take over as acting CEO on 1 January 2025, when Elin Mignérus will take parental leave. Starting January 1, 2025, Mats Wallnér will take over as acting CEO, as
Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (5 November 2024)
Reading Time: 2 minutes STORA ENSO OYJ STOCK EXCHANGE RELEASE 6 November 2024 at 13:30 EET Stora Enso Oyj received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 5 November 2024. On 5 November 2024, BlackRock’s
GAMOMAT Grows its Gaming for the Climate Initiative with Alexandria Fire Collaboration with WeForest
Reading Time: 2 minutes GAMOMAT, one of the leading independent software developers for slot games, has grown its Gaming for the Climate initiative by adding Alexandria Fire to further its mission of climate action. Gaming for the Climate is a passion project that launched
Vermiculus opens new office in Umeå to support continued growth
Reading Time: 2 minutes New location in one of the strongest fintech hubs in the Nordics strengthens Vermiculus’ capacity to meet global demand. Umeå, November 6, 2024, Vermiculus, a global provider of trading, clearing, and CSD technology, is growing rapidly and is pleased to announce
BioStock: Biosergen’s CEO: “I’m optimistic that we may cure patients”
Reading Time: < 1 minute Biosergen recently announced the completion of treatment for the first cohort of patients in its proof-of-concept trial for its antifungal drug candidate BSG005. Most patients improved significantly, reflecting BSG005’s potential as a life-saving therapy. The next step involves dose escalation for
New board member of CLS buys shares in the company and the CEO and EVP Operations increase their shareholdings
Reading Time: 2 minutes Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) today announces that the Company’s new Board member Peter Mantas, the CEO, Dan J. Mogren, and EVP Operations, Jimmy Johansson, have purchased a total of 22,000 Class B shares in
Gentoo Media: Invitation to Q3 2024 results presentation
Reading Time: < 1 minute Gentoo Media Inc. publishes its interim report for the third quarter 2024 before market opening on Wednesday 13 November 2024. Jonas Warrer, CEO, will host a presentation of the Q3 2024 results via livestream at 09:00 CET. The presentation will
Navamedic launches Eroxon[®] in Finland
Reading Time: 2 minutes Oslo, 6 November 2024 – Building on the successful product launch of Eroxon® in Norway and Sweden earlier this year, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, is now launching Eroxon®
The exercise period for subscription of shares through exercise of warrants of series TO5 begins today
Reading Time: 4 minutes NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE